tirzepatide .5 4-Week Tirzepatide 5mg | FDA-Approved Diabetes
Description
Patients with diabetes should be monitored for retinopathy, particularly if they have pre-existing disease, and those taking insulin or sulfonylureas should be aware of increased hypoglycaemia risk
Diabetes Care 2019;42:22722281 [DOI] [PubMed] [Google Scholar] 56
Abbott, Alexandra N
Review your progress monthly
